Lade Veranstaltungen

1st Joint Annual Meeting and 15th AGAH Annual Meeting 2006

19. Februar 2006 - 21. Februar 2006
Annual Meeting 2006, Düsseldorf

Transatlantic Strategies in Early Drug Development

Announcement

February 19-21, 2006, Düsseldorf

The third joint meeting of the AGAH with the ACCP (American College of Clinical Pharmacology) took place in February 2006 in Düsseldorf. Various international speakers from pharmaceutical industry, universities and competent authorities present new concepts and discussed actual issues in the fields of human pharmacology.

 

Presentations of the Annual Meeting 2006


J. Barrett

1100_Barrett
Approaching the In Silico Child


B. Bernhard

B_Bernhard_SV_28.02.06
Can Healthcare Systems Afford Targeted Medicines?


H. Fuder

H._Fuder_IV_02.03.06_01
Gaps Between Biomarkers and Surrogate Endpoints: CNS


R. Krishna

Krishna_SII_28.02.06_01
Approaches to First-In-Man and Beyond: Early Evidence of Target Engagement with Biomarkers and Innovative Clinical Trial Designs.


J. Lesko

1500_Lesko
Tools to Reduce Phase III Trial Failures.


J. Lütz

J._L_tz_SVII_06.03.06_01
Perspective of the German Medicines Agency (BfArM). BfArM after reorganisation of the structure.


B. Meibohm

B._Meibohm_SIII_28.02.06
Interplay between Drug Metabolizing Enzymes


J. Schentag

J._Schentag_SIV_01.03.06_01
The Gap Between Biomarkers and Surrogate Endpoints in the Development of Anti-Infectives.


B. Schug

B._Schug_WS_C_09.03.06
Drug Interaction Studies


T. Sudhop

EU-IMPD_02
What is required for first into man? The EU IMPD.


S. Throm

Throm_SVII_01.03.06_01
Innovation or Stagnation – Perspective of Pharmaceutical Industry.


G. Wensing

1200_Wensing
From Preclinical Data to Proof of Concept – Strategies for First to Man Studies.


M. Zühlsdorf

1630_Z_hlsdorf
The gap between biomarkers and surrogate endpoints Oncology

19. Februar 2006 - 21. Februar 2006

1st Joint Annual Meeting and 15th AGAH Annual Meeting 2006

Annual Meeting 2006


Düsseldorf
Deutschland